Casper Robert F
Division of Reproductive Sciences, University of Toronto, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital; and TRIO Fertility, Toronto, Ontario, Canada.
Fertil Steril. 2017 Mar;107(3):521-522. doi: 10.1016/j.fertnstert.2017.01.008.
In this views and reviews series of articles, we focus on the long-term medical management of endometriosis in lieu of surgery. The development of noninvasive biomarkers will facilitate the early diagnosis of endometriosis and early medical management. We discuss the use of oral progestin-only as first line treatment in place of oral contraceptives. Future medical treatments may be curative rather than simply suppressive or palliative. The section on surgery mainly pertains to failed medical management or specific types of endometriosis which require surgical excision.
在这个观点与综述系列文章中，我们聚焦于子宫内膜异位症不通过手术的长期药物管理。非侵入性生物标志物的发展将有助于子宫内膜异位症的早期诊断和早期药物管理。我们讨论仅使用口服孕激素作为一线治疗来替代口服避孕药。未来的药物治疗可能具有治愈性，而不仅仅是抑制性或姑息性的。关于手术的部分主要涉及药物治疗失败或需要手术切除的特定类型的子宫内膜异位症。
